User profiles for Peter J. Ell

Peter Ell

Professor. UCL
Verified email at nhs.net
Cited by 54399

Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial

…, DH Sinnett, A Fleissig, D Clarke, PJ Ell - Journal of the …, 2006 - academic.oup.com
Background: Sentinel lymph node biopsy in women with operable breast cancer is routinely
used in some countries for staging the axilla despite limited data from randomized trials on …

Non-[18F] FDG PET in clinical oncology

AM Groves, T Win, SB Haim, PJ Ell - The lancet oncology, 2007 - thelancet.com
PET is an exquisitely sensitive molecular imaging technique using positron-emitting
radioisotopes coupled to specific ligands. Many biological targets of great interest can be imaged …

Delivering affordable cancer care in high-income countries

R Sullivan, J Peppercorn, K Sikora, J Zalcberg… - The lancet …, 2011 - thelancet.com
The burden of cancer is growing, and the disease is becoming a major economic expenditure
for all developed countries. In 2008, the worldwide cost of cancer due to premature death …

The role of positron emission tomography in the management of pancreatic cancer

F Pakzad, AM Groves, PJ Ell - Seminars in nuclear medicine, 2006 - Elsevier
The role of positron emission tomography (PET) and PET/computed tomography (CT) in the
assessment of a patient presenting with cancer of the pancreas is discussed in the overall …

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.

…, I Resche, DP Quick, FM Grund, PJ Ell… - Journal of Clinical …, 1998 - ascopubs.org
PURPOSE To evaluate the effectiveness and safety of samarium-153 (153Sm) lexidronam (EDTMP)
in a double-blind, placebo-controlled study. PATIENTS AND METHODS Patients …

Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer

O Sartor, RH Reid, PJ Hoskin, DP Quick, PJ Ell… - Urology, 2004 - Elsevier
OBJECTIVES: A Phase III randomized trial was designed to assess the effectiveness of
samarium-153 ( 153 Sm)-lexidronam for palliation of bone pain in patients with hormone-…

[PDF][PDF] Available generic names for trilobites

PA Jell, JM Adrain - Memoirs-Queensland Museum, 2002 - academia.edu
… PAJ thanks Pete Palmer who engaged in an extensive mutually beneficial crosscheck of
the Cambrian listing against his database (SYNPLUS). We are grateful to Zhang Wentang, …

[BOOK][B] Nuclear medicine in clinical diagnosis and treatment

PJ Ell, SS Gambhir - 2005 - Soc Nuclear Med
This third edition is dedicated to Professor IPC Murray, who conceptualized the first edition
of this classic textbook by stating,“It reflects the significant changes that have occurred in the …

A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study

…, DC Costa, DJ Pennell, EM Prvulovich, PJ Ell… - European journal of …, 2002 - Springer
There are no large studies available to guide the selection of thallium (Tl), methoxyisobutylisonitrile
(MIBI) or tetrofosmin (Tf) for myocardial perfusion imaging. Our objective was to …

Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas

…, WA Weber, J Bomanji, A Perren, PJ Ell… - Journal of Nuclear …, 2011 - Soc Nuclear Med
Glucagon-like peptide-1 (GLP-1) receptor imaging is superior to somatostatin receptor
subtype 2 (sst 2 ) imaging in localizing benign insulinomas. Here, the role of GLP-1 and sst 2 …